NVIDIA
NVDA
Tesla
TSLA
Xiaomi Corp. Unsponsored ADR Class B
XIACY
4
Alibaba
BABA
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
HAE Haemonetics
- 64.570
- -0.360-0.55%
Close Feb 27 16:00 ET
- 64.570
- 0.0000.00%
Post 17:14 ET
3.24BMarket Cap25.42P/E (TTM)
66.020High64.080Low1.04MVolume64.580Open64.930Pre Close67.25MTurnover2.09%Turnover Ratio28.20P/E (Static)50.24MShares97.97052wk High3.58P/B3.21BFloat Cap58.80052wk Low--Dividend TTM49.73MShs Float142.110Historical High--Div YieldTTM2.99%Amplitude6.344Historical Low64.792Avg Price1Lot Size
Haemonetics News
Haemonetics | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(5.6%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital Research Global Investors(8.7%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.27%),Wellington Group Holdings LLP(8.27%), etc.
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Galvin Roy
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Simon, Christopher
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Bryant Diane M
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director COYLE MICHAEL J
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director ABERNATHY ROBERT E
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Lloyd Emerson
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Dockendorff Charles J
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director KROLL MARK W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Zane Ellen M
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Pomeroy Claire
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Simon, Christopher
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Llorens Josep